Funding Independent Medical Education Grants

$1,995.00

Funding Independent Medical Education Grants 1.8 is the eighth module of the 10-part Medical Affairs Product Launch Series.  This module explores independent medical education grant activities that occur throughout the launch window.  

This module also contains profiles to provide a comprehensive depiction of all key indicators levels during the product lifecycle.  In developing this module, Cutting Edge Information’s analysts collected surveys from and consulted with a series of medical affairs leaders at several top pharmaceutical, biotechnology and medical device companies. 

To learn more about the other modules in the Medical Affairs Product Launch Series and the benefits of subscribing to the entire series, click here 

 Download Now!speak-to-an-expert

Funding Independent Medical Education Grants

Funding Independent Medical Education Grants 1.8 is the eighth module of the 10-part Medical Affairs Product Launch Series. Based on primary research collected directly from executives leading top medical affairs teams, this module examines independent medical education grant activities, team budgets and staffing levels across product lifecycle stages. Data reveal how teams adjust resource and activity levels throughout the product lifecycle to maximize the impact of IME programs. Additionally, this module profiles two company teams — one supporting a niche product and the other a common product — to provide a comprehensive depiction of all key indicator levels during the product lifecycle.

  • Publication Date: August 2017
  • Pages: 33
  • Figures: 19

To learn more about the other modules in the Medical Affairs Product Launch Series and the benefits of subscribing to the entire series, click here.

Reasons to Buy Funding Independent Medical Education Grants

Identify factors that influence independent medical education grant activity timelines: Generally, teams do not begin to focus on IME grants until late in the product lifecycle.  However, not all teams adhere to this model.  This module’s data break down activity start by product type – niche, common and blockbuster. Data show that product type can be a powerful predictor of team IME grant activity timelines. 

Benchmark independent medical education grant budget levels, staffing and funded events, by event type, throughout the product lifecycle: Independent medical education programs, including in-person and online events, are a key component to increasing treatment and disease awareness. Use this module’s resource benchmarks to successfully fund and implement an independent medical education grant launch strategy.   

Examine two company team profiles to serve as useful examples for your team’s independent medical education grant resource and activity levels: Through detailed profiles, this research reveals that many teams allocate resources and personnel based on different timelines.  Use this study to evaluate your independent medical education grant activity levels and benchmark them against competitors.

Number of IME Grants Funded for In-Person Events

Surveyed medical affairs teams fund more in-person than online IME events.  Figure 1.8.7 shows the number of in-person IME event grants funded by surveyed teams during each product lifecycle stage.  Two of three surveyed teams fund more in-person events during and after product launch year than before.  

  • Both teams from Companies 3 and 5 fund a maximum of six in-person events. 
  • Company 3’s US team and Company 5’s EU and Canada team — both supporting niche products — fund their maximum number of in-person events during launch year or the first year on market.
  • Company 3’s team does not begin to fund in-person IME grants until launch year.  Teams supporting niche products typically begin to fund IME grants earlier in the product lifecycle.  Company 3’s team’s late start might be explained by the fact that it is a small company and could have a smaller pool of resources with which to fund grants.  

Examples of companies that have participated in this study:

Participating Companies